Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
Open Access
- 3 September 2020
- journal article
- research article
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 15 (1) , 1-12
Abstract
Background: Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity and mortality. There is limited knowledge on the health-related quality of life (HRQoL) of long-term patients in OAT. This study measures HRQoL and self-perceived health of long-term patients on OAT, compares the scores to a Norwegian reference population, and assesses changes in these scores at 1-year follow up. Methods: We conducted a nested prospective cohort study among nine OAT outpatient clinics in Norway. 609 OAT patients were included, 245 (40%) followed-up one year later. Data on patient characteristics, HRQoL, and self-perceived health was collected. HRQoL was assessed with the EQ-5D-5L, which measures five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) on a five-point Likert scale (from “no problems” to “extreme problems”). An UK value set was applied to calculate index values (from 0 to 1) for the EQ-5D-5L and compare them to a Norwegian reference population. Self-perceived health was measured with EQ-VAS (from 0 to 100). Results: Mean (standard deviation (SD)) EQ-5D-5L index value at baseline was 0.699 (0.250) and EQ-VAS 57 (22) compared to 0.848 (0.200) and 80(19) for the Norwegian reference population. There were large variations in EQ-5D-5L index values, where 43% had > 0.8 and 5% had < 0.2 at baseline. The lowest EQ-5D-5L index values were observed for female patients, age groups older than 40 years and for methadone users. At follow-up, improvements in HRQoL were observed across almost all dimensions and found significant for mobility and pain/discomfort. Mean (SD) overall index value and EQ-VAS at follow up were 0.729 (0.237) and 59 (22) respectively. Conclusion: The average HRQoL and self-perceived health of OAT patients is significantly lower than that of the general population, and lower than what has been found among other severe somatic and psychiatric conditions. Around 34% had very good HRQoL, higher than average Norwegian values, and around 5% had extremely poor HRQoL.Keywords
Funding Information
- Norges Forskningsråd (no. 269855)
- Helse Vest (Åpen prosjektstøtte)
This publication has 44 references indexed in Scilit:
- Integrated Treatment of Substance Use and Psychiatric DisordersSocial Work in Public Health, 2013
- Mortality among people who inject drugs: a systematic review and meta-analysisBulletin of the World Health Organization, 2013
- Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysisDrug and Alcohol Dependence, 2012
- Quality of Life Profiles and Changes in the Course of Maintenance Treatment Among 1,015 Patients With Severe Opioid DependenceSubstance Use & Misuse, 2010
- Health-related quality of life in diabetes: The associations of complications with EQ-5D scoresHealth and Quality of Life Outcomes, 2010
- Quality of Life Among Heroin Users on Buprenorphine versus Methadone MaintenanceThe American Journal of Drug and Alcohol Abuse, 2007
- Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent populationDrug and Alcohol Dependence, 2006
- Determinants of Health-Related Quality of Life of Opiate Users at Entry to Low-Threshold Methadone ProgramsEuropean Addiction Research, 2006
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders?Drug and Alcohol Review, 1996